Get started
ILLUMINAILLUMINAILLUMINA

ILLUMINA

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals Bonds

1ILMN chart


Full chart

Key facts today

Illumina's CFO Ankur Dhingra revealed that 25% of revenue comes from government research, primarily NIH grants, highlighting potential impacts on the company if NIH funding decreases.
Analyze the impactAnalyze the impact

1ILMN upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪20.21 B‬ EUR
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−8.96 EUR
Net income (FY)
‪−1.05 B‬ EUR
Revenue (FY)
‪4.08 B‬ EUR
Shares float
‪157.81 M‬
Beta (1Y)
1.38

Employees


Employees (FY)
‪12.01 K‬
Change (1Y)
+510 +4.43%
Revenue / Employee (1Y)
‪375.02 K‬ EUR
Net income / Employee (1Y)
‪−96.67 K‬ EUR

About Illumina, Inc.


Sector
Health Technology
Industry
Biotechnology
CEO
Jacob Thaysen
Website
illumina.com
Headquarters
San Diego
Founded
1998
FIGI
BBG01K3XH438
Illumina, Inc. engages in the development, manufacturing, and marketing of life science tools and integrated systems for large-scale analysis of genetic variation and function. It operates through the Core Illumina segment, which serves customers in the research, clinical and applied markets fields, and enables the adoption of a variety of genomic solutions. The firm's products include instruments, kits and reagents, selection tools, and software and analysis. Its services include sequencing and microarray services, proactive instrument monitoring, and instrument services, training, and consulting. The company was founded by David R. Walt, John R. Stuelpnagel, Anthony W. Czarnik, Lawrence A. Bock, and Mark S. Chee in April 1998 and is headquartered in San Diego, CA.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

1ILMN news



Ideas



See all ideas 

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

1ILMN highest yielding bonds


ILMN5150650
Illumina, Inc. 2.55% 23-MAR-2031
Yield to maturity
5.77%
Maturity date
Mar 23, 2031
ILMN5886317
Illumina, Inc. 4.65% 09-SEP-2026
Yield to maturity
4.99%
Maturity date
Sep 9, 2026
ILMN5508412
Illumina, Inc. 5.75% 13-DEC-2027
Yield to maturity
4.93%
Maturity date
Dec 13, 2027
ILMN5508411
Illumina, Inc. 5.8% 12-DEC-2025
Yield to maturity
4.91%
Maturity date
Dec 12, 2025

Explore more bonds 

Sparks


Curated watchlists where 1ILMN is featured.

See all sparks 

Frequently Asked Questions


The current price of 1ILMN is 127.46 EUR — it has decreased by −0.34% in the past 24 hours. Watch ILLUMINA stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on MIL exchange ILLUMINA stocks are traded under the ticker 1ILMN.
1ILMN stock has fallen by −8.75% compared to the previous week, the month change is a −5.71% fall, over the last year ILLUMINA has showed a 48.76% increase.
We've gathered analysts' opinions on ILLUMINA future price: according to them, 1ILMN price has a max estimate of 241.22 EUR and a min estimate of 113.96 EUR. Watch 1ILMN chart and read a more detailed ILLUMINA stock forecast: see what analysts think of ILLUMINA and suggest that you do with its stocks.
1ILMN reached its all-time high on Nov 7, 2024 with the price of 143.46 EUR, and its all-time low was 84.74 EUR and was reached on Nov 28, 2023. View more price dynamics on 1ILMN chart.
See other stocks reaching their highest and lowest prices.
1ILMN stock is 2.49% volatile and has beta coefficient of 1.38. Track ILLUMINA stock price on the chart and check out the list of the most volatile stocks — is ILLUMINA there?
Today ILLUMINA has the market capitalization of ‪19.81 B‬, it has decreased by −7.54% over the last week.
Yes, you can track ILLUMINA financials in yearly and quarterly reports right on TradingView.
ILLUMINA is going to release the next earnings report on Feb 6, 2025. Keep track of upcoming events with our Earnings Calendar.
1ILMN earnings for the last quarter are 1.02 EUR per share, whereas the estimation was 0.79 EUR resulting in a 29.74% surprise. The estimated earnings for the next quarter are 0.87 EUR per share. See more details about ILLUMINA earnings.
ILLUMINA revenue for the last quarter amounts to ‪969.99 M‬ EUR, despite the estimated figure of ‪969.95 M‬ EUR. In the next quarter, revenue is expected to reach ‪1.02 B‬ EUR.
1ILMN net income for the last quarter is ‪633.19 M‬ EUR, while the quarter before that showed ‪−1.86 B‬ EUR of net income which accounts for 134.12% change. Track more ILLUMINA financial stats to get the full picture.
No, 1ILMN doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 21, 2024, the company has ‪12.01 K‬ employees. See our rating of the largest employees — is ILLUMINA on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ILLUMINA EBITDA is ‪1.23 B‬ EUR, and current EBITDA margin is 7.50%. See more stats in ILLUMINA financial statements.
Like other stocks, 1ILMN shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ILLUMINA stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ILLUMINA technincal analysis shows the neutral today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ILLUMINA stock shows the neutral signal. See more of ILLUMINA technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.